Correlation Between Sonnet Biotherapeutics and Kura Oncology
Can any of the company-specific risk be diversified away by investing in both Sonnet Biotherapeutics and Kura Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonnet Biotherapeutics and Kura Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sonnet Biotherapeutics Holdings and Kura Oncology, you can compare the effects of market volatilities on Sonnet Biotherapeutics and Kura Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonnet Biotherapeutics with a short position of Kura Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonnet Biotherapeutics and Kura Oncology.
Diversification Opportunities for Sonnet Biotherapeutics and Kura Oncology
0.88 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Sonnet and Kura is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Sonnet Biotherapeutics Holding and Kura Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kura Oncology and Sonnet Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonnet Biotherapeutics Holdings are associated (or correlated) with Kura Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kura Oncology has no effect on the direction of Sonnet Biotherapeutics i.e., Sonnet Biotherapeutics and Kura Oncology go up and down completely randomly.
Pair Corralation between Sonnet Biotherapeutics and Kura Oncology
Given the investment horizon of 90 days Sonnet Biotherapeutics is expected to generate 1.62 times less return on investment than Kura Oncology. In addition to that, Sonnet Biotherapeutics is 2.43 times more volatile than Kura Oncology. It trades about 0.05 of its total potential returns per unit of risk. Kura Oncology is currently generating about 0.21 per unit of volatility. If you would invest 726.00 in Kura Oncology on November 18, 2024 and sell it today you would earn a total of 102.00 from holding Kura Oncology or generate 14.05% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sonnet Biotherapeutics Holding vs. Kura Oncology
Performance |
| Timeline |
| Sonnet Biotherapeutics |
| Kura Oncology |
Sonnet Biotherapeutics and Kura Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sonnet Biotherapeutics and Kura Oncology
The main advantage of trading using opposite Sonnet Biotherapeutics and Kura Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonnet Biotherapeutics position performs unexpectedly, Kura Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kura Oncology will offset losses from the drop in Kura Oncology's long position.| Sonnet Biotherapeutics vs. ZyVersa Therapeutics | Sonnet Biotherapeutics vs. Allarity Therapeutics | Sonnet Biotherapeutics vs. Immix Biopharma | Sonnet Biotherapeutics vs. Cns Pharmaceuticals |
| Kura Oncology vs. Protagonist Therapeutics | Kura Oncology vs. Merus BV | Kura Oncology vs. Replimune Group | Kura Oncology vs. Kalvista Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |